Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 2

Conditions

Breast Neoplasms 4Hot Flashes 3Sleep Wake Disorders 1Depression 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Acupuncture Therapy 5Gabapentin 4Venlafaxine Hydrochloride 3Estrogens, Conjugated (USP) 3liposomal amphotericin B 2Tamoxifen 2Magnesium Oxide 2Hypnosis 2Control Groups 2Citalopram 2oxybutynin 1black cohosh root extract 1bazedoxifene 1Zolpidem 1Testosterone 1Tablets 1Soybean Proteins 1Solifenacin Succinate 1Sodium Chloride 1Sertraline 1Progesterone 1Pregabalin 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Mindfulness 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Isoflavones 1Hypericum extract LI 160 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hot Flashes × Venlafaxine Hydrochloride × Breast × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

NCT00084669 2010-04-28

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Massachusetts General Hospital

Phase NA Completed
119 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sleep Wake Disorders, Carcinoma, Lobular, Hot Flashes

NCT00198250 2008-11-14

Venlafaxine for Hot Flashes After Breast Cancer

Indiana University

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡